Brought to you by:
Founding fathers of EVAR set to gather to mark 40 years of aortic stent graft development
The 40-year history of endovascular aneurysm repair (EVAR) of the aorta wends a circuitous route, from behind the Iron Curtain in Soviet Ukraine, to Buenos Aires, Argentina, points east and west in the U.S., and far beyond. It’s a journey…
The top 10 most popular Vascular Specialist stories of May 2024
In April, the most read stories from Vascular Specialist include new data from the C-GUARDIANS pivotal investigational device exemption (IDE) trial presented at the Leipzig Interventional Course (LINC) 2024 (28–31 May, Leipzig, Germany); recently released randomised data show cyanoacrylate glue…
CX united: Vascular world set to converge with challenging cases
The World Federation of Vascular Societies (WFVS) is bringing the vascular world together at CX 2024 to chew over both challenging cases and leadership challenges. The pair of sessions is part of the legacy left by Professor Roger M. Greenhalgh,…
Paclitaxel controversy: Yes, device restrictions did cause harm
“Unfortunately, we are doing worse for our patients today,” were the sobering thoughts of Eric Secemsky (Boston, United States) during a late-breaking presentation in this morning’s Peripheral Arterial Controversies programme. Among several presentations on paclitaxel safety, he reported that: yes,…
BEST-CLI vs. BASIL-2: Different questions yield different answers
Medical editor Malachi Sheahan III, MD, takes a look at seemingly conflicting results from the landmark BEST-CLI and BASIL-2 trials, and asks what they really reveal. This past April, BASIL-2 chief investigator Andrew Bradbury, MD, presented trial results at the…
CX 2023: Statins save lives after aortic repair regardless of dose
Statin treatment after aortic repair is associated with improved long-term survival, while dose does not matter. This was the key message from a first-to-podium presentation delivered by Kevin Mani (Uppsala University, Uppsala, Sweden) at the 2023 Charing Cross (CX) International…
Vascular community split over ‘death’ of traditional carotid stenting
A debate between two prominent carotid interventionists—Peter Schneider, MD, professor of vascular and endovascular surgery at University of California San Francisco in San Francisco, and Domenico Valenti, MD, professor of vascular surgery at King’s College London in London, England—on the…
BASIL-2 points towards endovascular-first revascularization strategy in CLTI patients
A question from Manj Gohel, MD, from Cambridge University Hospitals in Cambridge, England, on what the 2023 Charing Cross (CX) International Symposium audience should take back to their multidisciplinary team meetings from the first-time presentation of BASIL-2 led chief investigator…
On 45th anniversary, CX Symposium chairman credits Chicago vascular surgical tandem for enduring success
The occasion of a seminal meeting held in Chicago by former Society for Vascular Surgery (SVS) Presidents John J. Bergan, MD, and James S.T. (Jimmy) Yao, MD, played a central role in the formation of the world-renowned Charing Cross (CX)…
Artificial intelligence could make endovascular aortic repair outcomes more predictable, CX 2022 hears
At the 2022 Charing Cross (CX) International Symposium (April 26–28) in London, England, Tom Carrell, MD, a vascular surgeon in Cambridge, England, and founder of Cydar Medical, delivered a Podium 1st presentation titled “Making endovascular aortic repair outcomes more predictable: Artificial…